SR One Capital Advisors

SR One is a transatlantic biotechnology venture capital firm, headquartered in the San Francisco Bay Area, that collaborates with entrepreneurs and investment partners in an effort to build elite biotechnology companies.

SR One is a transatlantic biotechnology venture capital firm, headquartered in the San Francisco Bay Area, that collaborates with entrepreneurs and investment partners in an effort to build elite biotechnology companies. The Company’s mission is to translate innovative technologies and scientific discoveries into next-generation medicines with the potential to benefit patients with significant unmet medical needs. SR One leadership has worked together to build and invest in biotechnology companies for more than a decade. Working alongside the investment team, SR One’s venture partners bring deep operational experience to help company creation initiatives and support portfolio companies with financing and corporate strategies. Since the spin out from GSK in 2020, SR One has raised over $1 billion and founded and/or invested in over 20 companies. SR One has offices in Redwood City, CA, and Philadelphia, PA, in the US and London in the UK.